Purpose: Single-cell nested polymerase chain reaction (PCR) 
INTRODUCTION
Preimplantation genetic diagnosis (PGD) is currently used in assisted reproduction laboratories to identify the presence of specific gene mutations, mutations associated with sex-chromosomes, and aneuploidies (1) . Polymerase chain reaction (PCR) and fluorescent in situ hybridization technology allows for the rapid detection of heritable genetic diseases. Some of these diseases, such as cystic fibrosis, Duchenne's muscular dystrophy, hemophilia, and now Marfan's syndrome can be detected in early preimplantation-stage embryos created using in vitro fertilization (IVF) techniques (2) (3) (4) .
In this report we describe the detection of a mutation in the fibrillin gene located on chromosome 15. Mutations in fibrillin give rise to a autosomal dominant disease known as Marfan's syndrome (4). Originally described in the late 1800s, this connective tissue disease is caused by defects in the fibrillin protein found in microfibrils, a component of the extracellular matrix associated with elastin in tissues such as the aorta and ligaments, and some nonelastic tissues (4, 5) . Three major systems are affected: ocular, cardiac, and skeletal. A common phenotype is overgrowth of long bones.
The fibrillin protein is encoded by a gene, which is composed of 57 exons. It contains several critical cysteine residues found within EGF-like repeats which are responsible for stability and calcium binding. Because this gene is so large and there are so many important structural elements to the sequence, most patients have mutations unique to their pedigree (6, 7) .
A 26-year-old male affected with the disease carried a mutation in exon 12 in chromosome 15. The heterozygous mutation, C1585T, induces a premature stop codon which caused the patient to have severe aortic distention and root repair. He and his wife sought PGD in hopes of having a child that would not inherit the mutation. The patients were required to sign informed consent forms for the procedure, which was approved by the Institutional Review Board (IRB) of New York University Medical Center (Protocol H 6321). All procedures involving embryos occurred at NYU.
MATERIALS AND METHODS

In Vitro fertilization
The IVF patient, a 25-year-old nulligravida female, underwent follicle stimulation involving luteal downregulation with leuprolide acetate and daily human menopausal gonadotropin stimulation followed by an injection of human chorionic gonadotropin (hCG). Transvaginal ultrasound-guided follicular aspiration was performed 36 hr post-hCG. This was the couple's fourth attempt at assisted reproduction coupled with PGD. Thirteen oocytes were obtained and intracytoplasmic sperm injection (ICSI) was performed 3-4 hr postretrieval. Fertilization was confirmed by the presence of two pronuclei at 16-18 hr after ICSI. Embryos were cultured in HTF medium (Irvine Scientific, Santa Ana, CA) supplemented with maternal serum until day 3 postretrieval.
Embryo Biopsy Procedure
On the morning of day 3, the embryos (five-to eight-cell stage) were biopsied using micromanipulation procedures described previously (6) . In brief, a small hole was made in the zona pellucida with acid Tyrode's solution, and one blastomere was gently removed by mouth pipette suction. Each blastomere was washed and carefully placed into individual sterile PCR microcentrifuge tubes containing lysis buffer (50 mM dithiothreitol in 200 mM potassium hydroxide). Following the addition of neutralization buffer, the DNA was heat denatured (10 min at 65°C).
PCR Analysis
Single-cell nested PCR was performed using primers designed to amplify the region containing the mutation within exon 12 on chromosome 15. The primers (0.5 jxM used in Round 1 were as follows: sense, 5'-AGAATTATGAGGTATTGCTTATG-3'; and antisense, 5'-CAGTTAGCATATATGTCCCAC-3'. Thirty-five cycles (95°C for 30 sec, 58°C for 30 sec, and 72°C for 45 sec) were run at a final concentration of 1.5 mM Mg 2+ and 2.5 U/50 ul Taq polymerase (Boehringer Mannheim, Indianapolis, IN). In Round 2 (nested), an additional 35 cycles were run using the following primers: sense, 5'-GTGCTTTGCAGATGT-TGATG-3'; and antisense, 5'-CAGTTAGCATATATG-TCCCAC-3'.
Following PCR, 5 ul of the product was incubated for 1 hr at 37°C with 5 U/0.5 ul of Dde1 restriction enzyme (New England Biolabs, Beverly, MA) and then analyzed by electrophoresis on a 1.5% agarose gel. Band migration was analyzed according to the known size of expected fragments with and without the mutation. The final product was 179 base pairs in the blastomeres without the mutation, whereas blastomeres containing the mutation also presented 52-and 127-base pair fragments (Figs. 1 and 2 ).
RESULTS
Nine of 13 oocytes fertilized normally following ICSI. Biopsies were successfully performed and a nucleated blastomere was obtained for each of the nine embryos. PCR analysis provided migrating bands for each embryo (Fig. 2) . No DNA fragments were visible in the two blank lanes. A 179-base pair fragment is detectable in all lanes; however, lanes 5, 6, 8, 13, and 14 contained two additional two bands (52 and 127 base pairs), which are the result of the introduction of the Ddel restriction endonuclease site in the heterozygote mutation. Given these results, we were confident of the genetic makeup of each embryo.
Embryo Transfer
On the evening of day 3, the four embryos that produced the blastomeres bearing only one population of migrating bands (lanes 2, 4, 7, and 12 in Fig.  2 ) were transferred to the patient's uterus using a Wallace catheter. The transfer was uneventful. Two months prior to this cycle a small endocervical submucous myoma had been removed by hysteroscopic resection.
A positive B-hCG was obtained on day 12 posttransfer and the patient has an ongoing pregnancy. Subsequent amniocentesis has revealed a normal male fetus. We have also analyzed the amniocentesis products using the nested PCR procedure described above. There was no evidence of the mutation; only a 179-base pair fragment was present following incubation of the PCR product with Dde1 restriction endonuclease.
DISCUSSION
As a result of the many advances made by scientists in the human genome project and, by molecular biologists in the industry of DNA sequence analysis, we will soon be able to identify many deleterious gene defects in human embryos by coupling either PCR analysis or fluorescent in situ hybridization (FISH) with assisted reproduction technology. Many centers currently use this technology to identify sex chromosome linked mutations by detecting the sex of the embryos using specific repeats in the X and Y chromosomes (7, 8) . A simpler method than PCR, FISH allows the investigator to view the entire DNA spread in either metaphase or interphase chromosomes and count the fluorescent signals corresponding to an individual chromosome or mutation (9) . Although FISH is ideal for sex determination and aneuploidy detection, many heritable gene defects are single amino acid substitutions that are not suitable for FISH detection. The use of combined PCR and FISH on the same blastomere to confirm diagnosis has also been developed but it has not been used to the same extent as either PCR or FISH (11, 12) .
Although single-cell PCR has been used for PGD, there are many potential problems associated with this technique. Single-cell PCR has been erroneous in the past, the result of amplification failure or the amplification of only one allele (13) . Such misdiagnoses are not acceptable and are terribly painful for the parents. We have previously reported transcript-targeted PGD for a patient with a different heterozygous mutation resulting in Marfan's syndrome which attempts to diminish the possibility of misdiagnosis (14) . One should take great care when pursuing such technology in the lab. The fibrillin gene is extremely large and has many exons. Like cystic fibrosis, Marfan's syndrome can be caused by a variety of different mutations which must be screened for very carefully. Once the appropriate mutation is identified in a patient, procedures such as that presented here can be used with confidence to ensure that the mutation is not passed on to their children.
